Table 2.
Statistically significant blood plasma, serum and urine metabolites according to the VIP scores of PLS-DA (VIP > 1)
| Biofluid | δ 1Η (ppm) | VIP scores | Metabolites |
|---|---|---|---|
| Plasma | 3.71 | 7.16 | Glucose, leucine, cholesteryl ester |
| 3.85 | 6.99 | Glucose, serine, GlcNAc | |
| 3.67 | 5.54 | GlcNAc, glycerol | |
| 3.73 | 4.66 | Glucose, alanine, cholesteryl ester | |
| 1.29 | 4.28 | –(CH2)n- fatty acids | |
| 1.33 | 3.68 | Lactic acid | |
| 3.79 | 3.56 | Glucose, lysine, GlcNAc | |
| 3.83 | 3.46 | Glucose, serine, sugar | |
| 1.27 | 3.39 | –(CH2)n- fatty acids | |
| 1.31 | 3.33 | –(CH2)n- fatty acids | |
| Serum | 2.05 | 4.83 | Proline, GlcNAc |
| 3.67 | 4.82 | Glycerol | |
| 3.89 | 4.26 | Unassigned | |
| 3.85 | 3.78 | Serine, glucose | |
| 3.57 | 3.71 | Glycine, glycerol, glucose | |
| 1.29 | 3.68 | –(CH2)n- fatty acids | |
| 3.65 | 3.44 | Myo-inositol | |
| 3.73 | 3.38 | Alanine, glucose | |
| 3.79 | 3.34 | Lysine, glucose | |
| 3.87 | 3.33 | Unassigned | |
| Urine | 7.67 | 2.31 | 3-methylhistidine |
| 3.37 | 2.30 | Unassigned singlet | |
| 8.23 | 2.29 | Metabolite with substituted imidazole ring | |
| 7.85 | 2.13 | Hippuric acid, urocanic acid | |
| 8.13 | 2.06 | Metabolite with substituted imidazole ring | |
| 7.31 | 1.93 | Urocanic acid, metabolite with substituted imidazole ring | |
| 3.89 | 1.92 | Mannitol, unassigned | |
| 7.59 | 1.91 | Metabolite with substituted imidazole ring | |
| 8.27 | 1.90 | Metabolite with substituted imidazole ring | |
| 8.01 | 1.89 | Metabolite with substituted imidazole ring |